Drugs & Targets Verzenio with endocrine therapy gets FDA approval for early breast cancer October 15, 2021Vol.47 No.38
Drugs & Targets Keytruda combination gets FDA approval for first-line cervical cancer treatment October 15, 2021Vol.47 No.38
Drugs & Targets FDA authorizes first e-cigarette products, alarming cancer prevention advocates October 15, 2021Vol.47 No.38
Drugs & Targets Qinlock approved in Switzerland for fourth-line gastrointestinal stromal tumor October 15, 2021Vol.47 No.38
Drugs & Targets Mayo Clinic collaborates with Personalis to expand cancer genomic testing October 15, 2021Vol.47 No.38
Drugs & Targets Pillar Biosciences, Labcorp collaborate on next-generation sequencing October 15, 2021Vol.47 No.38
Drugs & TargetsFree FDA approves Tecartus for relapsed or refractory B-cell precursor ALL October 08, 2021Vol.47 No.37
Drugs & TargetsFree FDA recognizes MSK database of molecular tumor marker information October 08, 2021Vol.47 No.37
Drugs & TargetsFree EMA validates relatlimab + nivolumab application for advanced melanoma October 08, 2021Vol.47 No.37
